BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16371056)

  • 1. ABO-mismatched marrow transplantation: removal of mismatched donor red blood cells by "washing" with recipient's matched red blood cells in a closed system.
    Humpe A; Beck C; Claviez A; Riggert J
    Transfusion; 2005 Dec; 45(12):1985-7. PubMed ID: 16371056
    [No Abstract]   [Full Text] [Related]  

  • 2. ABO-incompatible pediatric bone marrow transplantation: a simple method to remove red blood cells from small volume marrow grafts.
    Chan KW; Herd SL; Stanley CE; Wadsworth LD
    Bone Marrow Transplant; 1991 Dec; 8(6):473-6. PubMed ID: 1790427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation with major ABO blood group incompatibility using automated removal of red blood cells from incompatible bone marrow by CS 3000 plus.
    O-Charoen R; Soiprasert P; Chaisiripoomkere W; Jootar S; Chiewsilp P
    Transplant Proc; 1994 Aug; 26(4):2352-3. PubMed ID: 8066772
    [No Abstract]   [Full Text] [Related]  

  • 4. [A simple and cell-sparing method for obtaining stem cells slightly contaminated by erythrocytes in bone marrow transplantation with major ABO incompatibility].
    Mayer G; Sugg U; Wernet D; Schneider W
    Beitr Infusionther Klin Ernahr; 1987; 18():316-20. PubMed ID: 3326590
    [No Abstract]   [Full Text] [Related]  

  • 5. Transplantation of major AB0-incompatible bone marrow: removal of red cells by dextrane sedimentation.
    Müller A; Hermann J; Fuchs D; Prager J; Burger E; Kob D; Goetz I; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):475-9. PubMed ID: 2480293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow.
    Ho WG; Champlin RE; Feig SA; Gale RP
    Br J Haematol; 1984 May; 57(1):155-62. PubMed ID: 6372850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in Polish conditions. Method for removal of red cells from the transplant in the case of major blood group incompatibility.
    Wiktor-Jedrzejczak W; Ratajczak MZ; Szczylik C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):261-7. PubMed ID: 2639626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Removal of erythrocytes from the bone marrow before blood group-incompatible hematopoietic transplant using a polysaccharide-ditrizoate density gradient centrifugation].
    Ratajczak MZ; Wiktor-Jedrzejczak W
    Pol Tyg Lek; 1987 Jul; 42(30):907-10. PubMed ID: 3313322
    [No Abstract]   [Full Text] [Related]  

  • 12. [ABO-incompatible bone marrow transplantation; removal of red blood cells from donor marrow by using Hemonetics model 30 blood cell separator].
    Kai S; Ifuku H; Ohe Y; Maeda K; Hara H; Nagai K; Shinohara Y; Misawa M; Kanamaru A
    Rinsho Ketsueki; 1986 Jan; 27(1):22-9. PubMed ID: 3520044
    [No Abstract]   [Full Text] [Related]  

  • 13. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.
    Damodar S; George B; Mammen J; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2005 Aug; 36(3):233-5. PubMed ID: 15908965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
    Bensinger WI; Buckner CD; Clift RA; Williams BM; Banaji M; Thomas ED
    Transplant Proc; 1987 Dec; 19(6):4605-8. PubMed ID: 3321630
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells.
    Fang B; Song Y; Zhao RC; Han Q; Cao Y
    Am J Hematol; 2007 Aug; 82(8):772-3. PubMed ID: 17573692
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation from a major ABO-incompatible donor. Infusion of hemopoietic stem cells isolated by Ficoll-Hypaque method.
    Harada M; Aoyagi N; Kondo K; Ishino C; Odaka K; Matsue K; Yoshida T; Hattori K
    Transplantation; 1983 Feb; 35(2):191-2. PubMed ID: 6131551
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
    Sniecinski IJ; Petz LD; Oien L; Blume KG
    Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
    [No Abstract]   [Full Text] [Related]  

  • 18. Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation.
    Stussi G; Huggel K; Schanz U; Passweg JR; Seebach JD
    Transplant Proc; 2005 Mar; 37(2):1385-7. PubMed ID: 15848728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.
    Jin NR; Hill R; Segal G; Still B; Petersen FB; Amos D; Buckner CD; Clift R; Bensinger W; Martin P
    Exp Hematol; 1987 Jan; 15(1):93-8. PubMed ID: 3536547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.